Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study

We formulated a traditional Chinese medicine (TCM) prescription, Hanshiyi Formula (HSYF), which was approved and promoted by the Wuhan Municipal Health Commission for treating mild and moderate coronavirus disease 2019 (COVID-19). We aimed to evaluate the effect of HSYF on the progression to severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jiaxing, Yan, Shiyan, Wang, Han, Zhang, Ying, Zheng, Yujiao, Wu, Haoran, Li, Xiuyang, Gao, Zezheng, Ai, Yanke, Gou, Xiaowen, Zhang, Lei, He, Liyun, Lian, Fengmei, Liu, Baoyan, Tong, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416080/
https://www.ncbi.nlm.nih.gov/pubmed/32791263
http://dx.doi.org/10.1016/j.phrs.2020.105127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416080/
https://www.ncbi.nlm.nih.gov/pubmed/32791263
http://dx.doi.org/10.1016/j.phrs.2020.105127

Ejemplares similares